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converting enzyme lead to an amplification of the
morphological changes and an upregulation of the
substance P system in a muscle overuse model
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Background: We have previously observed, in studies on an experimental overuse model, that the tachykinin
system may be involved in the processes of muscle inflammation (myositis) and other muscle tissue alterations. To
further evaluate the significance of tachykinins in these processes, we have used inhibitors of neutral endopeptidase
(NEP) and angiotensin-converting enzyme (ACE), substances which are known to terminate the activity of various
endogenously produced substances, including tachykinins.
Methods: Injections of inhibitors of NEP and ACE, as well as the tachykinin substance P (SP), were given locally outside
the tendon of the triceps surae muscle of rabbits subjected to marked overuse of this muscle. A control group was
given NaCl injections. Evaluations were made at 1 week, a timepoint of overuse when only mild inflammation and
limited changes in the muscle structure are noted in animals not treated with inhibitors. Both the soleus and gastrocnemius
muscles were examined morphologically and with immunohistochemistry and enzyme immunoassay (EIA).
Results: A pronounced inflammation (myositis) and changes in the muscle fiber morphology, including muscle fiber
necrosis, occurred in the overused muscles of animals given NEP and ACE inhibitors. The morphological changes were
clearly more prominent than for animals subjected to overuse and NaCl injections (NaCl group). A marked SP-like expression,
as well as a marked expression of the neurokinin-1 receptor (NK-1R) was found in the affected muscle tissue in response to
injections of NEP and ACE inhibitors. The concentration of SP in the muscles was also higher than that for the NaCl group.
Conclusions: The observations show that the local injections of NEP and ACE inhibitors led to marked SP-like and NK-1R
immunoreactions, increased SP concentrations, and an amplification of the morphological changes in the tissue. The
injections of the inhibitors thus led to a more marked myositis process and an upregulation of the SP system.
Endogenously produced substances, out of which the tachykinins conform to one substance family, may
play a role in mediating effects in the tissue in a muscle that is subjected to pronounced overuse.
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A pronounced muscle inflammation (myositis) and a de-
rangement of the structure of muscle tissue occur in in-
flammatory myopathies [1,2]. Muscle inflammation and
alterations of muscle structure also occur in response to
muscle overuse after heavy exercise and in situations
with repetitive strain injury [3]. We have recently* Correspondence: sture.forsgren@anatomy.umu.se
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reproduction in any medium, provided the orstudied the development of myositis, as well as muscle
tissue derangement, in response to muscle overuse in
the triceps surae muscle of the rabbit [4]. Using this
overuse model, we have observed that there is an upreg-
ulation in the expression of tachykinin [substance P
(SP)] and the SP-preferred receptor [the neurokinin-1
receptor (NK-1R)] in muscle areas showing inflamma-
tion/tissue derangement [5,6]. All these features were
clearly noticeable after 3-6 weeks of experimental over-
use and to a small extent after an experimental period oftd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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involved in the myositis/derangement processes.
SP is the most well-known peptide in the tachykinin
family. It is found in the C fiber population of primary af-
ferent neurons and is released from their central and per-
ipheral endings [7,8]. SP is also present in non-neuronal
cells such as white blood cells [9]. SP has marked pro-
inflammatory properties [10-12], as evidenced by partici-
pation in neurogenic inflammation [13,14] and in the pro-
cesses of extravasation and accumulation of inflammatory
cells [15]. Increased SP effects are considered to lead to an
up-regulation of NK-1R expression, consistent with an ac-
tivation of the NK-1 R [16,17].
Exogenous administration of SP via injections or via
topical treatment has been tested experimentally and has
been shown to have effects in a large number of infla-
mmatory/destructive events, as well as in repair and
wound-healing processes [18-20]. These include repair
processes in models of Achilles tendon rupture [21,22].
Local administration of SP outside the Achilles tendon has
been found to accelerate hypercellularity and angiogenesis
within this tendon in an experimental tendinopathy-like
situation [23].
The activity of tachykinins, such as SP, and certain
other peptide mediators is terminated by enzymatic deg-
radation and by receptor inactivation. The most import-
ant enzymes are neutral endopeptidase (NEP), which
degrades SP in the extracellular space [24-26], and
angiotensin-converting enzyme (ACE) [27]. Local injec-
tions of SP and/or endopeptidase inhibitor are reported
to have a booster effect on endogenous SP production
[22]. The present study was undertaken in order to fur-
ther determine the role for tachykinin involvement in
muscle derangement and inflammation processes. We
have used the rabbit overuse model to study this. We
performed the combined exercise/electrical stimula-
tion experiment for 1 week and in order to obtain pro-
nounced effects of endogenously produced substances,
we gave local treatments with ACE- and NEP-inhibitors.
SP was also given. It was hypothetized that the exogen-
ous treatments with ACE- and NEP-inhibitors, as well as
SP, would lead to pronounced activation of the NK-1R




In the experiments, female New Zealand white rabbits
with a weight of approximately 4 kg (age ranging from 6
to 9 months) were utilized. In total, the investigation in-
cluded evaluations of 16 animals. All the animals were
subjected to an exercise protocol leading to marked
overuse of the triceps surae muscle. The muscle overuse
was combined with injection treatment (see below).Exercise procedure
The animals were exposed to an exercise procedure that
was performed according to previously described proce-
dures [28], with some modifications [4-6,23]. The rabbits
were kept under anaesthesia, induced by i.m. injections
of diazepam (5 mg/ml; 0.2 ml/kg) and fentanylfluanison
(0.2-0.3 ml/kg), throughout the experiment. Fentanyl-
fluanison (0.1 ml/kg) was injected each 30-45 min dur-
ing the experiment in order to maintain the anaesthesia.
The experiments lasted for 2 hours. For analgesia,
buprenorphine (0.01-0.05 mg/kg) was given s.c. after
each experimental session. The experiment was repeated
every second day for one week (4 exercise sessions in
total).
In order to achieve passive repetitive flexions and ex-
tensions of the right ankle joint, an apparatus (“kicking
machine”) was used. A pneumatic piston attached to the
foot produced the movements. An active contraction
was furthermore induced by electrical stimulation via
surface electrodes (Pediatric electrode 40 426A, Hewlett
Packard, Andover, MA, USA) placed 2 cm apart over
the triceps surae muscle of the right leg. This active con-
traction occurred during the plantar flexion phase. The
stimulation was synchronized with the plantar flexion
movement of the piston by a microswitch, which trigged
the stimulator unit (Disa stimulator Type 14E, Disa
Elektronik A/S, Herlev, Denmark). An impulse of 0.2 ms
duration was delivered 85 ms after the initiation of the
plantar flexion at an amplitude of 35-50 V. The move-
ment frequency was 150 movements per minute. The
left leg was not attached to the kicking machine and the
pelvis was strapped down. In-between the experimental
periods, the animals were kept in ordinary cages allow-
ing good freedom of movement. For further details
about the apparatus and the exercise protocol, see
[4-6,23].
Injection treatments
Injections were given in the loose connective tissue out-
side the Achilles tendon, i.e. in the paratenon region, of
the right leg. The injections were given directly after
each of the exercise regimens. The substances injected
were Captopril (C) (c4042; Sigma), DL-Thiorphan (Th)
(T 6031; Sigma), substance P (SP) (S6883; Sigma) and
NaCl. Captopril is an angiotensin-converting enzyme in-
hibitor (ACE inhibitor) and DL-Thiorphan inhibits the
activity of neutral endopeptidase (NEP). NEP is also
called enkephalinase and neprilysin or common acute
lymphoblastic leukemia antigen or CD10 [29].
Injections were performed as follows: a) Substance P
(10-8 μmol/ml) and Captopril (30 μmol/kg) both in dis-
tilled water (volume: 1 ml) + Dl-Thiorphan (500 μg/ml;
0.02 ml) (5 animals), b) Captopril (30 μmol/kg, dissolved
in distilled water, volume 1 ml) + DL-Thiorphan (500 μg/
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mals). The groups are further referred to as the SP + C +
Th group, the C + Th group and the NaCl group.
Collection of muscle samples, fixation and sectioning
The animals were sacrificed, using an overdose of Pento-
barbital, the day after the last exercise. The triceps surae
muscles were dissected out. Directly thereafter the
muscle samples were transported on ice to the labora-
tory. The distal parts of the soleus and gastrocnemius
muscles (5-8 × 10 mm) were dissected out. Specimens
from all samples were collected and processed in three
ways: Immersion fixed, directly embedded/frozen or dir-
ectly frozen in liquid nitrogen. For all types of speci-
mens, specimens from all the various muscles were
obtained. Thus, for both the soleus and gastrocnemius
muscles, 5-6 specimens were generated for each experi-
mental condition.
For fixation, specimens were fixed by immersion over-
night at 4°C in an ice-cold solution of 4% formaldehyde
in 0.1 M phosphate buffer (pH 7.0). These specimens
were thereafter thoroughly washed in Tyrode’s solution
containing 10% sucrose at 4°C overnight, mounted on
thin cardboard in OCT embedding medium (Miles La-
boratories, Naperville, Ill.), and frozen in propane chilled
with liquid nitrogen. Other specimens were, as described
above, directly embedded and frozen. Both types of spec-
imens were stored at -80°C and from both types, series
of 7-8 μm thin sections were cut using a cryostat. The
sections were mounted on slides precoated with
chrome-alum gelatine and were then processed for
morphology (chemically unfixed samples) or immuno-
histochemistry and morphology (chemically fixed sam-
ples). Other specimens weighing approximately 30 mg
were directly frozen in liquid nitrogen. They were fur-
ther used for EIA analyses.
From one of the experimental groups (the SP + C + Th
group) specimens, conforming to all three types of speci-
mens as described above, were collected from both the
right and left legs.
Processing for morphology (haematoxylin & eosin)
Sections in the series were stained in Harris Haematoxy-
lin solution for 2 min. They were then rinsed in distilled
water, dipped in 0.1% acetic acid for a few seconds,
followed by washing in running water. Counterstaining
was achieved by immersion in eosin for 1 min. The sec-
tions were dehydrated in ethanol and mounted in
Permount.
Morphological semiquantitative evaluations
Evaluations with respect to the magnitude of morpho-
logical changes were made. The evaluations were basedon the haematoxylin & eosin (H&E) stainings. The eval-
uations were made blinded.
The degree of inflammatory infiltrates in the tissue
and the degree of presence of abnormal connective tis-
sue areas, necrotic muscle fibers and variations in
muscle fiber sizes as well as the degree of occurrence of
internal nuclei were all assessed. An overall estimation
for all these parameters was performed. The evaluations
included an overall estimation of the entire sections
from both the chemically unfixed and fixed specimens
of each muscle.
The following pattern of scoring was used: 0 = no
changes; morphology resembling that seen in normal
muscle tissue, 1 = mild degree of changes, 2 =moderate
degree of changes, 3 =marked changes, 4 = very marked
changes. The scoring was relative, i.e. the magnitude of
changes in one muscle was related to those in others.
The mean value for scores for the different groups was
then calculated. The significance level was set at the 0.05
level. The scoring is a simplified scoring method in rela-
tion to the one used in our previous morphological
study on the effects of 1,3 and 6 weeks of experiment
[4]. Based on the experience we obtained from that
study, we consider that the scoring procedures that were
presently used are reliable. Thus, the degree of occur-
rence of the different abnormal features analyzed paral-
lelled each other.
Immunohistochemistry
Staining procedures for demonstration of substance P (SP)
and NK-1R
Two antibodies for staining for demonstration of SP were
used. One of the SP antibodies and the NK-1 R antibody
were goat polyclonal antibodies (see below). The staining
procedures for these antibodies conformed to those previ-
ously described [5,6]. This included the use of 5% normal
donkey serum (code no: 017-000-121, Jackson ImmunoR-
esearch Lab. Inc., PA) as normal serum and FITC-
conjugated AffiniPure donkey antigoat IgG (705-095-147;
Jackson ImmunoResearch Lab Inc, dilution 1:100) as sec-
ondary antiserum. Mounting was performed in Vecta-
shield Mounting Medium (H-1000) (Vector Laboratories,
Burlingame, CA) and examination was carried out in a
Zeiss Axioscope 2 plus microscope equipped with an
Olympus DP70 digital camera.
Staining using a monoclonal SP antibody was also per-
formed. In this case, an initial incubation with Triton X-
100 was done, followed by incubation in 5% normal don-
key serum and incubation with the primary antibody,
diluted in PBS with BSA, in a humid environment. Incu-
bation was performed for 60 min at 37°C. Another incuba-
tion in normal donkey serum followed, after which the
sections were incubated with secondary antiserum. As sec-
ondary antiserum, tetramethylrhodamine isothiocyanate
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025-150) (Jackson ImmunoResearch, PA), diluted 1:40 in
PBS supplemented with 0.1% BSA, was used. Incubation
with secondary antiserum proceded for 30 min at 37°C.
The procedures for mounting and examination were as
described above.
As an alternative procedure for demonstration of SP
and NK-1R immunoreactions, sections were initially pre-
treated with acid potassium permanganate for 2 min, a
procedure found to enhance specific immunofluores-
cence reactions [30]. After this pretreatment, the proce-
dures described above followed. Both procedures (with
or without acid potassium permanganate treatment)
gave in principle similar results. There were, however,
some differences in staining intensities and levels of
background reactions, why it was useful to analyse sec-
tions by using both types of procedures.Stainings for demonstration of desmin and CD31
Immunostaining for desmin was used in order to verify
the occurrence of muscle fiber necrosis since it is well-
known that necrotic muscle fibers show no or negligible
desmin immunoreactivity [31,32]. CD31 is a well-known
marker of endothelia of blood vessels.
The CD31 staining was performed using visualization
with FITC-conjugated donkey anti-mouse IgG (715-095-
15) (Jackson ImmunoResearch), dilution used 1:100, and
as normal serum, normal donkey serum with PBS in BSA
was utilized. For the evaluation of desmin reaction pat-
terns, double staining desmin/NK-1R was made. FITC-
conjugated AffiniPure donkey anti-goat IgG (705-095-147)
was used as secondary antibody for visualization of NK-1R
and 5% normal donkey serum in PBS was used as normal
serum. Concerning desmin immunodetection, rabbit anti-
mouse immunolobulins/TRITC (R0276) (Dako, Denmark)
was used as secondary antiserum, 1:40 dilution being used,
and 5% normal rabbit serum in PBS with BSA as normal
serum. Mounting was made in Vectashield Mounting
Medium (H-1000).Antibodies and control stainings
SP antibodies An affinity purified goat polyclonal SP
antibody was utlized. It was obtained from Santa Cruz
Biotechnology (code: sc-14104) and was used at a dilution
of 1:25-1:50. This antibody is raised against a peptide map-
ping within an internal region of preprotachykinin 1 of
human origin and is recommended for detection of ma-
ture SP and all isoforms of the protachykinin 1 precursor
of various species [mouse, rat and human origin]. Accord-
ing to “Human Protein Reference Database” and “BLAST-
Basic Local Alignment Search Tool”, the protein sequence
of rabbit protachykinin 1 shows at least 85% identity with
human protachykinin 1.A rat monoclonal SP antibody was also used. It was ob-
tained from Biogenesis, Poole, UK (code: 8450-0505). It
was used at a dilution of 1:50-1:100. The antibody is re-
ported to recognize the COOH terminal end of SP and
has been previously used for immunohistochemical de-
tection of SP in experimental animals and man [5,33].
Control stainings included the use of SP blocking sub-
stance (code: sc14104P; Santa Cruz) (20-50 μg/ml anti-
serum) and SP peptide (full length SP peptide; S6883;
Sigma) (50 μg/ml antiserum). Ordinary stainings with
the SP antisera were performed in parallel. Other control
stainings conformed to stainings when the primary anti-
bodies were excluded (buffer instead of the antibody).
NK-1R antibody A NK-1R antibody produced in goats
was used (code: sc-5220, Santa Cruz). It is an affinity
purified polyclonal antibody raised against a peptide
mapping within an internal region of NK-1R of human
origin. It was used at a dilution of 1:50-1:100 in 0.1%
PBS. It has been previously used in studies on immu-
noexpression patterns in rabbit muscle tissue [6]. Con-
trol stainings included the use of NK-1R blocking
substance (sc-5220P) (50 μg/ml antiserum). Ordinary
stainings for NK-1R were made in parallel. As was the
case concerning stainings for SP, other control stainings
conformed to stainings when the primary antibody was
excluded.
CD31 and desmin antibodies Mouse monoclonal anti-
bodies against CD31 and desmin were used. The CD31
antibody was obtained from Dako, Glostrup, Denmark
(code: M0823) and was used at a dilution of 1:100. It is a
marker of the endothelial cells of blood vessel walls and
has previously been used with reliable results in our la-
boratory [23]. The desmin antibody was also obtained
from Dako, Glostrup, Denmark (code: Ab D33) and was
utilized at a dilution of 1:100. It is by the supplier re-
ported to be specific for desmin and to not show reactiv-
ity with other types of intermediate filaments. This
antibody has been evaluated in previous studies [4].
Processing for EIA
Tissue homogenization
After being frozen in liquid nitrogen (see above), the
samples were homogenised, by mechanical homoge-
nization using a Precellys 24 tissue homogenizer (Bertin
Technologies, Saint Quentin en Yvelines, Cedex, France),
in a 100 mM Tris-HCl buffer, pH 7.0, containing 1 M
NaCl, 2% BSA, 4 mM EDTA, 0.2% Triton X-100 (pH 7.0),
0.02% Na-azide and the protease inhibitors Pepstatin A
(0.1 μg/ml), Aprotinin (5 μg/ml), Antipain (0.5 μg/ml),
Benzamidin (167 μg/ml) and PMSF (5.2 μg/ml). All the
protease inhibitors were purchased from Sigma, Germany.
Tissue and buffer were mixed in a 1:20 ratio. The
Figure 1 Muscle tissue of the gastrocnemius (A) and soleus
(inset, A) muscles. The animals had been subjected to muscle
overuse coupled with local injections with NaCl. The muscle tissue
shows a normal organization, and very occasional presence of
necrotic muscle fibers (middle in inset). Bar = 50 μm. Muscle tissue of
gastrocnemius muscles from two animals subjected to muscle
overuse coupled with local injections with SP + C + Th;
non-exercised side (B), exercised side (C). There is a variability
in muscle fiber appearance, a very marked inflammatory infiltrate
(to the right, B) and necrotic muscle fibers (arrowheads, C). There
is a presence of very small muscle fibers in the inflammatory infiltrate
(arrows, B). Bars = 50 μm.
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ogenisation procedure, the tissue samples were centrifuged
in +4°C, 13 000 g, for 15 min. The supernatant was then
transferred to a new Eppendorf tube and stored at -80°C.
EIA procedure
The concentration of SP in the muscle samples was eval-
uated using commercially available enzyme immuno-
assay SP kits (Phoenix Pharmaceuticals, Burlingame,
CA, USA). The sequence of the peptide detected con-
forms to the full-length of SP. 100% cross-reactivity is
also reported for SP 2-11 – SP 5-11. Less than 0.01%
cross-reactivity is reported for SP 7-11, neuropeptide K
and neurokinin A and 0% for neurokinin B. The assays
were performed in accordance with the instructions
from the manufacturer. In order to obtain comparable
results between different plates, reference samples were
included in the various analyses. The levels of SP were
normalized to the weights of the tissue samples, i.e. the
values are expressed as pg/mg tissue.
Statistics
All data are expressed as mean and standard deviations
(SD) are given. A one way ANOVA in combination with
post hoc comparisons by use of Least Square Difference
(LSD) was used for analysis of differences between the
different groups. The paired t test was used for the
evaluation of possible differencees in SP concentration
between the experimental and non-experimental sides
(concerning SP + C + Th group). The normality for the
data for each group was examined and the distribution
was found to be normal or approximately normal. All
the statistical analysis was performed by software SPSS
(PASW Statistics 20). A p-value < 0.05 was considered to
be significant.
Ethics
The study protocol was approved by the local ethical
committee at Umeå University (A34/07, A95/07). A li-
censed breeder had bred all the animals for the sole pur-
pose of being used in animal experiments. All efforts




Extensive morphological changes occurred for both the
soleus and gastrocnemius muscles in the animals given
local injections with C + Th or SP + C + Th (Figures 1
and 2). The changes were particularly marked in the
C + Th group. In the SP + C + Th animals, for which
both the experimental (exercised) and contralateral sides
were examined, the morphological changes appeared
similar in both sides.The morphological changes corresponded particularly
to pronounced inflammatory cell infiltrations, occur-
rence of necrotic muscle fibers (i.e. fibers that were
markedly infiltrated by inflammatory cells) and the fre-
quent presence of internal nuclei in the muscle fibers as
well as an abnormal presence of wide areas with loose
connective tissue (Figures 1, 2 and 3A). Muscle fibers
Figure 2 Tissues of soleus muscle of animals subjected to muscle overuse coupled with injections of C + Th. There is a very marked
inflammatory infiltrate in (A), most of the area shown being occupied by infiltrated white blood cells and loose connective tissue. There is an
infiltration of white blood cells and a marked presence of connective tissue in-between muscle fibers in (B) and (C). The muscle fibers in (C) show
frequently internal nuclei (arrows). In the inset in (A), two parallel sections stained with H&E (figure to the left) and stained for demonstration of
CD31 (figure to the right), are shown. There are numerous CD31 reactions in the inflammatory/connective tissue area (triangles), reactions which
based on what is known for CD31 are related to endothelia of blood vessels. Asterisks at muscle fibers. Bars = 100 μm (A), 50 μm (B, C).
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tory areas (Figure 1B). The morphological changes were
not randomly occurring in the specimens but were
mainly concentrated to certain areas (“myositis areas”).
When compared with the muscles of the NaCl group,
it was noted that the morphological changes were clearlyFigure 3 A series of sections of a soleus muscle specimen of an
animal subjected to muscle overuse and injections with C + Th.
The sections were stained with H&E (A), and processed for SP (antibody
sc-14104) (B) and NK-1R (C). There are numerous white blood cells in
a connective tissue area located in-between muscle fibers. There is
presence of SP-like and NK-1R immunoreactions in these cells. A large
number of the cells in this area are eosinophils. Bars = 25 μm.more pronounced for the muscles of the C + Th and SP
+ C + Th groups (c.f. Figure 1A). Morphological alter-
ations such as occurrence of necrotic fibers were only
sometimes observed in the NaCl group (Figure 1A).Semiquantitative evaluations
Semiquantitative evaluations of the magnitude of the occur-
ring morphological changes were made (see Methods).
a) Soleus muscle
There was a clearly higher mean value concerning
the degree of morphologic changes in the C + Th
group as compared with the NaCI group (3.8 vs. 1.5,
p = 0.0002). A high mean value was also noted for
the SP + C + Th group (non-experimental side) as
compared to the NaCI group (3.0 vs. 1.5, p = 0.061).
There was a higher mean value for the muscle of
the experimental side in the SP + C + Th group as
compared to that of the NaCI group, but the
difference was not statistically significant (2.3 vs.
1.5, respectively, p = 0.236). The mean values are
shown in Table 1.
b) Gastrocnemius muscle
There were higher mean scores for the SP + C + Th
group (both experimental and non-experimental
sides) and the C + Th group as compared to the
NaCI group. However, the differences were not
statistically significant. The mean values for all the
various groups are shown in Table 1.Immunohistochemical observations
C + Th and SP + C + Th groups
SP-like immunoreactions The two SP antibodies used
were directed against different epitopes (see Materials &
Methods). As will be described below, there was a differ-
ence in the reaction pattern for the two antibodies. We
further on use the terminology “SP-like” immunoreactivity
Table 1 Mean values of the scoring of morphological
changes and the mean values of SP concentations as
measured by EIA in the soleus (SOL) and gastrocnemius






Group SOL GM SOL GM
NaCI (n = 5) 1.5 ± 1.1 1.2 ± 0.4 240 ± 50 353 ± 147
SP + C + Th
(exp) (n = 5)
2.3 ± 0.8 2.0 ± 1.3 351 ± 75 (363) 511 ± 134#
SP + C + Th
(non-exp) (n = 5)
3.0 ± 1.1 2.1 ± 0.7 295 ± 67 450 ± 55
C + Th (n = 6) 3.8 ± 0.6# 2.2 ± 0.5 509 ± 160#▲□ (422) 531 ± 104#
For the SP + C + Th group, samples were obtained from both the experimental
(exp) and non-experimental (non-exp) sides. For the other groups, the samples
were solely from the experimental side. Values within brackets (concerning SP
concentration, SOL) are the mean values if samples for which CV was above
15% were excluded (CV was above 15% concerning values for in total 3
samples out of the 42 samples analyzed).
One way ANOVA in combination with post hoc comparisons was applied for
the analysis of differences between the groups concerning SP concentration.
Significance level was set at 0.05. Symbols concerning occurrence of statistical
significances are shown. #Significant difference as compared to NaCI group.
▲Significant difference between the C + Th group and the SP + C + Th group
(experimental side), □significant difference between the C + Th group and the
SP + C + Th group (non-experimental side).
Figure 4 Sections of soleus muscle specimens; C + Th group
(A-C) and SP + C + Th group, non-exercised side (D). The sections
were stained for SP (antibody sc-14104) (A,C) and NK-1R (B,D). In (A),
an arteriole with marked tachykinin-like/(SP-Like) immunoreactions in
its wall is seen (middle) and the region shown in (B) conforms to a
region with marked infiltration of white blood cells. SP-like/ immuno-
reactions (A) and NK-1R immunoreactions (B) are seen in white blood
cells (arrows). Parts of nerve fascicles are seen in (C) and (D). Immuno-
reactions are seen in these in both (C) and (D) (arrows). Bars = 25 μm.
Figure 5 A series of sections of a soleus muscle specimen from
the SP + C + Th group (non-exercised side). The sections were
stained with H&E (A), and processed for SP (antibody sc-14104) (B)
and NK-1R (C). Muscle fibers that largely are normal in appearance
(asterisk) and muscle fibers that are more or less filled with white
blood cells (triangles) (necrotic muscle fibers) are seen. Marked NK-1R
and to some extent also SP-like immunoreactions are abservable in the
white blood cells that have infiltrated into the necrotic muscle fibers.
There are also NK-1R and SP-like immunoreactions in white blood cells
located in the connective tissue spaces that separate the muscle fibers.
Note that there is also some unspecific autofluoresence reactions in
muscle fibers. In the inset in (A), the results of double-staining for NK-1R
(above) and desmin (below) are demonstrated. One muscle fiber shows
marked NK-1 R immunoreaction but no desmin immunolabelling
(triangle), whist others only show unspecific background raction after
NK-1 R staining but specific desmin immunolabelling (asterisks). The
former fiber can based on desmin reaction pattern be interpreted to be
a necrotic muscle fiber. Bars = 50 μm.
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bodies. The terminology “tachykinin-like” was used in a
previous study [5].
Marked SP-like immunoreactions were observed in
myositis areas and areas adjacent to these in the C + Th
group and both sides of the SP + C + Th group. The
magnitude of immunoreactions was especially high in
the C + Th group.
The SP-like immunoreactions were seen in the infil-
trating white blood cells, blood vessel walls and nerve
profiles. Reactions in white blood cells occurred for
such cells that were dispersed in connective tissue areas
(Figures 3B and 4A) as well as for such cells that were
coalesced into necrotic muscle fibers (Figure 5B). Blood
vessels showing SP-like immunoreactions in their walls
were mainly seen in myositis areas and areas that were
adjacent to these (Figure 4A). The nerve fascicles lo-
cated in these areas showed partially SP-like immunor-
eactions (Figure 4C). Frequent varicose nerve profiles
showing SP-like immunoreaction were seen in association
with blood vessel walls and in the connective tissue in
myositis areas (Figure 6).
Specific immunoreactions were obtained for nerve fi-
bers and white blood cells using both the polyclonal and
monoclonal antibodies, whilst specific immunoreactions
in the blood vessel walls were only obtained with the
polyclonal antiserum. The polyclonal antibody thus
depicts a broader tachykinin spectrum, the anti
body detecting all isoforms of the protachykinin 1
precursor.
Figure 6 SP immunoreactivity features (staining with antibody
8450-0505). The specimen was from the SP + C + Th group;
non-exercised side. There are frequent fine varicose nerve fibers
exhibiting SP-like immunoreaction outside the wall of an arteriole
(arrows, main figure) and in a connective tissue space (arrow,
inset). Bar = 25 μm.
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immunoreactions were noted for the C + Th group and
for both sides of the SP + C + Th group. As was the case
concerning the location of the marked SP-like immunor-
eactions described above, the NK-1R immunoreactions
were especially observed for myositis areas and areas
that were close to these. NK-1R immunoreactions oc-
curred for white blood cells of the inflammatory infil-
trates (Figure 3C) and were also detected in nerve
fascicles (Figure 4D). NK-1R immunoreactions were also
detected in necrotic muscle fibers (Figure 5C) and blood
vessel walls in myositis areas (not shown).Immunoexpression of desmin and CD31 It was clearly
obvious that the frequently occurring muscle fibers,
which based on the appearance after staining for H&E
were interpreted to represent necrotic muscle fibers,
were indeed desmin-negative (Figure 5A). Normally-
appearing muscle fibers were, on the other hand, show-
ing desmin immunoreaction (Figure 5A).
There were numerous blood vessels showing CD31-
immunoreaction in the areas composed of loose con-
nective tissue containing numerous white blood cells, i.e.
myositis areas (Figure 2A).NaCl group SP-like and NK-1R immunoreactions were
also detected in white blood cells, blood vessel walls and
nerve fascicles in the muscle tissue of the NaCl group,
but these reactions were of clearly lower degree and fre-
quency than those seen for the C + Th and SP + C + Th
groups. A parallel observation was, as commented on
above, that the morphological changes were also less
pronounced in the NaCl group (c.f. Figure 1A).
SP concentration
Soleus muscle
The SP concentration was significantly higher in the C +
Th group compared with the NaCI group (509 pg/mg
vs. 240 pg/mg, p < 0.001), and there was also a signifi-
cantly higher mean value in the C + Th group than in
the SP + C + Th group (experimental side) as well
(509 pg/mg vs. 351 pg/mg, p < 0.02) and similarly, there
was a difference between the C + Th group and the non-
experimental side of the SP + C + Th group (509 pg/mg
vs. 295 pg/mg, p = 0.001). There was a tendency of an
increase in SP concentration in the SP + C + Th group
(concerning both experimental and non-experimental
sides) as compared with the NaCI group. The tendency
was most pronounced for the experimental side. Never-
theless, the difference was not statistically significant. No
significant difference was found between experimental
and non-experimental sides for the SP + C + Th group
(p = 0.178). All values are presented in Table 1.
Gastronemius muscle
The SP concentration was significantly higher in the C +
Th group as compared with the NaCI group (531 pg/mg
vs. 353 pg/mg, p = 0.017, respectively) (Table 1). It was
also significantly higher in the SP + C + Th group (ex-
perimental side) as compared with the NaCI group
(511 pg/mg vs. 353 pg/mg, p = 0.039, respectively). No
significant difference was found between experimental
and non-experimental sides for the SP + C + Th group
(p = 0.316).
Discussion
The study shows that the local injections with NEP and
ACE inhibitors provoked the myositis/muscle derange-
ment processes that occur in response to the overuse. It
was evident that the muscles of animals that had been
given the local inhibitory substances showed a more pro-
nounced tissue derangement than those treated with
NaCl. The increase was most clearly seen for the soleus
muscle in the C + Th group. The present study also
shows that the local injections with C + Th and to some
extent also the injections with SP + C + Th led to more
marked NK-1R and SP-like immunoreactions in the
myositis areas and in the adjacent areas. There were
higher SP concentrations in the muscle tissue of these
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obvious that the morphological alterations and the upre-
gulations in expressions of SP/NK-1R were much more
noticeable for the C + Th and SP + C + Th groups than
for animals subjected to the overuse for 1w using our
model and when no injections were given [4-6].
There was a tendency for a more pronounced tissue
derangement/inflammation in the C + Th group as com-
pared to the SP + C + Th group. There was a significantly
higher SP concentration in the C + Th group compared
to the SP + C + Th group concerning the soleus muscle.
One explanation to the occurrence of the differences be-
tween the two groups can be the fact that exogenously
given tachykinin, such as SP, is short-lived, why the
major effects we see are those of the ACE and NEP in-
hibitors. For example, it was previously shown that the
plasma extravasation elicited by topical application of SP
onto rabbit joint capsule is short-lived, the high extrava-
sation initially seen not being observed 24 h after the ex-
periment [34]. Endogenous SP is also known to be stable
in human plasma in vitro whilst added exogenous SP
disappears from it rapidly [35,36]. Another explanation
to the differences between the C + Th and SP + C + Th
groups may be that it can not be excluded that the ex-
ogenously given SP to a certain extent leads to a down-
regulation of the endogenous SP production.Marked SP-like and NK-1R immunoreactions and
increased SP concentrations
The use of the polyclonal SP antibody showed that there
were immunoreactions in blood vessel walls. Reactions at
this location were not seen by the use of the monoclonal
SP antibody. The polyclonal SP antibody is directed
against all isoforms of the protachykinin 1 precursor, why
it is possible that not only SP but also other tachykinins
are involved in blood vessel function in the muscle tissue.
The marked SP-like/NK-1R immunoreactions that
were seen in myositis areas and areas adjacent to these
included immunoreactions for the frequently occurring
white blood cells and, as seen by use of the polyclonal
antibody, the walls of blood vessels. SP-like/NK-1R
immunoreactions occurred within large nerve fascicles
and frequent SP-like immunoreactive fine varicose pro-
files were also seen. The study also shows that the SP
concentration was increased due to the inhibitor treat-
ments, especially in the C + Th group.
These observations suggest that the NK-1R was acti-
vated and that a boostering of SP occurred due to the
local inhibitor injections. The latter suggestion is in ac-
cordance with findings by Steyaert and colloborators in
their studies on SP treatment for ruptured rat Achilles
tendons showing that exogenously administered SP had
a booster effect on endogenous SP production [22].Possible SP effects
It is well described that local SP treatments can have
inflammatory-mediating and destructive effects [10,12,19].
The NK-1R can on the whole have a significant role in the
damaging processes during the occurrence of injury and
inflammation [37].
Despite the well-known fact that tachykinins have pro-
inflammatory effects [10,12], the role for tachykinins like
SP in healing effects should also be considered. SP is
known to have trophic and healing effects [19,38], in-
cluding in the initial stages of Achilles tendon healing in
the rat [22]. Rats with high residual SP levels after
capsaicin-induced neuropathy showed more improve-
ments than those with low levels in the healing of the
rat Achilles tendon [39].
It is likely that other substances, in addition to tachy-
kinins, are also involved in the inflammatory and
reorganization processes that occur in the muscle tissue.
Accordingly, it is reported that although SP can evoke
an inflammatory respose in the knee joint, this effect is
unlikely to be a function on its own [34]. It should here
be emphasized that various peptides in the tachykinin
family can bind to the NK-1R [40]. We have also our-
selves noted that there is an enhanced expression of
TNF-alpha in the myositis process in the model used in
this study and it was concluded that tachykinin (SP) can
be involved in its upregulation [41]. Further studies will
reveal which other substances that are also involved. It
should here be emphasized that NEP not only hydro-
lyzes tachykinins but also enkephalins [24,42] and that
ACE degrades not only tachykinins but also bradykinin
[43]. ACE is also reported to degrade endothelin-1 and
possibly also CGRP [26]. This means that the C + Th
treatments not only leads to increased SP levels in the
tissue.
To summarize, it is presumable that tachykinins such
as SP, as is suggested for certain other situations [44],
can have double-edged effects in the processes of myo-
sitis/muscle derangement, tachykinins being involved in
both pro-inflammatory and reparative processes. In ac-
cordance with this concept, we noted in our previous
study on NK-1R expression patterns in myositis for ani-
mals excercised/electrically stimulated for 3-6 weeks and
for which animals no injections were given [6], an occur-
rence of NK-1R expression in both necrotic and regener-
ating muscle fibers. Further studies will reveal the
relationships between the pro-inflammatory and healing
effects.
Bilateral findings
In the study, muscle samples in the group treated with
SP + C + Th were analyzed concerning both the experi-
mental side and the contralateral side. It was found that
there were tendencies for more marked alterations of
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both sides, as compared to the NaCl group, the SP in-
crease being especially obvious for the gastrocnemius
muscle. This shows that unilateral exercise/electrical
stimulation parallelled by injection of local inflammatory-
modulating substances leads to effects also contralaterally.
Similarly, we have noted that morphological changes [4]
and occurrence of upregulations in tachykinin (SP-like) [5]
and NK-1 R [6] expressions are seen bilaterally in response
to the prolonged (3-6 weeks) exercise/electrical stimula-
tion protocol without injections being given. Our inter-
pretation has been that neural mechanisms are likely to be
involved as the morphological changes (the myositis and
muscle derangement) occurred focally and not generally
and as influences on the structure of nerve fascicles could
be observed. Nevertheless, further electrophysiological
and CNS studies are needed in order to prove this.
Conclusions
Previous studies have shown that there is an inflamma-
tory component in the muscle/tendon affection in re-
sponse to overuse [45]. In studies on flexor digitorum
tendons using a rat model of repetitive strain injury it
was shown that there was an exposure-dependent in-
crease in SP immunoexpression in the peritendon tissue
[3]. The present study gives new information on the in-
volvement of SP within muscle tissue in a condition of
marked muscle overuse.
In conclusion, it is here shown that the local injections
of C + Th markedly amplified the structural changes in
the muscle tissue and lead to increased SP-like and NK-
1R immunoexpressions in the myositis areas and in-
creased SP concentrations in the tissue. To a certain ex-
tent, the SP + C + Th treatment led to smilar changes.
The changes are likely to be attributed to increased ef-
fects of endogenously produced substances out of which
tachykinins can be important. It is thus possible that
these endogenously produced substances have a previ-
ously unrecognized importance in mediating effects on
muscle tissue in situations with pronounced overuse. It
remains for future studies to reveal if blocking of tachy-
kinin effects via use of NK-1 R blocking substances can
be of importance in reducing the tissue effects that
marked muscle overuse leads to.
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